Susquehanna International Group’s Phibro Animal Health PAHC Stock Holding History

Susquehanna International Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	9,500 +2,000	+27%	+$84.4K	﹤0.01%	11052
2026 Q1	$415K	Sell	7,500 -10,100	-57%	-$481K	﹤0.01%	10125
2025 Q4	$658K	Buy	17,600 +12,400	+238%	+$504K	﹤0.01%	8178
2025 Q3	$210K	Buy	+5,200	New	+$172K	﹤0.01%	10890
2022 Q4	–	Sell	-15,000	Closed	-$199K	–	13337
2022 Q3	$199K	Buy	+15,000	New	+$259K	﹤0.01%	10850
2019 Q3	–	Sell	-6,600	Closed	-$210K	–	10646
2019 Q2	$210K	Buy	+6,600	New	+$207K	﹤0.01%	9042

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group's PAHC Position: Q2 2026 in Review

Susquehanna International Group increased its Phibro Animal Health (PAHC) stake by 63% in Q2 2026, buying an estimated $177K and bringing the position to 10,904 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #10760.

Susquehanna International Group first reported a position in PAHC in Q2 2014 and has held it in 23 quarters since. The position peaked at $1.9M in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Susquehanna International Group held 10,904 shares of Phibro Animal Health worth $342K as of Q2 2026.
Susquehanna International Group bought 4,206 Phibro Animal Health shares in Q2 2026, an estimated $177K.
Phibro Animal Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #10760 holding.
Susquehanna International Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 23 quarters since.
Susquehanna International Group's Phibro Animal Health position peaked at $1.9M in Q3 2025.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.